National Brain Tumor Awareness Month

May is National Brain Tumor Awareness Month.  Driven by advancement in research, surgical techniques, genetic discoveries, and much more, it has never been a better time to take action on brain tumors. The National Brain Tumor Society (NBTS), an organization whose mission is to unrelentingly invest in, mobilize, and unite our community to discover a

Louisville CyberKnife Welcomes Alden Klarer, M.D.

Louisville CyberKnife announced that radiation oncologist Alden Klarer, M.D. has joined their cancer care treatment team. Dr. Klarer received her medical doctorate from the University of Louisville in Louisville, Kentucky, where she also completed her internship and residency. Dr. Klarer has had a strong interest in the field of oncology since taking her first job after college

Treating Metastatic Brain Tumors with CyberKnife Technology

Lung cancer often spreads to the brain.  About 10 percent of patients with non-small cell lung cancer (NSCLC) have brain metastases at their initial diagnosis and as many as 40 percent will eventually develop metastatic brain tumors at some stage during their illness. Vivian Wilson was part of that 40 percent.  The 57-year-old Kentucky resident

Cancer Screen Week 2020

Cancer Screen Week 2020According to the American Cancer Society, almost 607,000 people are expected to die from cancer in 2020. Regular screening can help find certain cancers early when they are most likely to be treated successfully. This Cancer Screen Week (Dec 7-11), help us raise awareness and learn more of the potentially lifesaving benefits

Types of Trigeminal Neuralgia: Typical vs. Atypical

Trigeminal neuralgia (TN) is a rare and excruciating nerve disorder that can occur when a blood vessel compresses the trigeminal nerve, the largest nerve in the head, and causes debilitating pain in various parts of the face and jaw region. Trigeminal neuralgia is usually categorized as typical or atypical, with symptoms differing depending on the

Hypofractionated Radiation Therapy for Prostate Cancer

As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments.  Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations

New Clinical Trials for Prostate Cancer Now Available

Two clinical trials opened for enrollment in late 2019 at UofL Health – James Graham Brown Cancer Center for eligible men with prostate cancer. “Since the Brown Cancer Center has these clinical trials available, we can offer our prostate cancer patients the latest cancer treatments,” Scott Silva, M.D., Ph.D. , radiation oncologist, said. Men with favorable intermediate risk

Vernon's Story

Vernon Traxler suffered from painful trigeminal neuralgia for over 16 years before he found relief with CyberKnife. Watch Vernon explain what those years felt like and how he feels now after being treated by CyberKnife.

Prostate Cancer Treatment and Sexual Function

When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration.  While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them.  That choice is often based on treatment outcomes and side effects, and